Ewa Jach

Ewa Jach, Ph.D., serves as the Head of R&D and Pharmacovigilance Inspection Management at UCB since June 2022, where leadership encompasses a global team focused on Health Authority inspections in GCP/GLP/GVP. With prior roles at UCB and substantial experience at Bristol Myers Squibb spanning over 17 years, Ewa has managed global clinical inspection management, quality assurance, and compliance across diverse therapeutic areas. Ewa's academic credentials include a Ph.D. from the University of Antwerp and a Master of Science from Jagiellonian University, reinforcing expertise in biological sciences.